United States · FDA National Drug Code directory
Ondansetron
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-1314_b16468ac-e482-41d2-ac22-966ad7807bcf
- Product NDC
- 71335-1314
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- Ondansetron
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20100412
- Source listing expiry
- 20261231
Source-listed ingredients
- ONDANSETRON — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 90 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1314-0) · 71335-1314-0
- 30 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1314-1) · 71335-1314-1
- 20 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1314-2) · 71335-1314-2
- 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1314-3) · 71335-1314-3
- 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1314-4) · 71335-1314-4
- 60 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1314-5) · 71335-1314-5
- 9 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1314-6) · 71335-1314-6
- 5 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1314-7) · 71335-1314-7
- 15 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1314-8) · 71335-1314-8
- 3 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1314-9) · 71335-1314-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →